10-Q: NexPoint Capital Reports Q2 2026 Results

NexPoint Capital, Inc. reported a net increase in net assets resulting from operations for the six months ended June 30, 2026, driven by unrealized appreciation on investments.

Summary

• NexPoint Capital, Inc. reported a net increase in net assets of $2,737,030 for the six months ended June 30, 2026, compared to a net decrease of $3,369,091 for the same period in 2025.
• Net investment income for the six months ended June 30, 2026, was $191,394, a decrease from $484,806 in the prior year's comparable period.
• The company's total investments at fair value increased to $38,359,807 as of June 30, 2026, from $37,591,400 as of December 31, 2025.
• Net asset value per share increased to $4.55 as of June 30, 2026, from $4.39 as of December 31, 2025.
• The portfolio is primarily composed of common stocks (40.7%), preferred stocks (29.5%), and LLC interests (17.0%).
• Healthcare remains the largest industry concentration at 37.2% of the portfolio.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as cautiously optimistic, with a net increase in assets but a decrease in net investment income compared to the prior year's comparable period.

Positives

• Net assets increased by $968,803 for the six months ended June 30, 2026, reaching $37,706,737.
• Total investments at fair value increased to $38,359,807 as of June 30, 2026.
• Net asset value per share increased to $4.55 as of June 30, 2026, up from $4.39 at the end of 2025.
• The company experienced a net change in unrealized appreciation of $3,263,182 for the six months ended June 30, 2026, contributing positively to net assets.

Negatives

• Net investment income decreased to $191,394 for the six months ended June 30, 2026, from $484,806 in the same period of 2025.
• Total expenses increased to $830,711 for the six months ended June 30, 2026, from $713,767 in the prior year's comparable period.
• The company's portfolio is heavily concentrated in common stocks (40.7%), making it susceptible to market volatility in that sector.

Risks

• Concentration risk due to the non-diversified nature of the company, with potential for significant fluctuations if a few issuers perform poorly.
• Illiquid securities risk, as many investments are in private companies and may be difficult to sell.
• Interest rate risk, as changes in interest rates can affect the value of fixed-rate investments and the cost of borrowing.
• Credit risk associated with debt securities, including the risk of non-payment of interest and principal.
• Counterparty credit risk for derivative transactions.
• Valuation uncertainty for Level 3 assets, which rely on unobservable inputs and subjective judgments.

Future Outlook

The company's investment objective is to generate high current income and long-term capital appreciation by investing in middle-market companies, syndicated floating rate debt, and CLOs, with an emphasis on healthcare. The company expects to generate cash flows primarily from interest and fees earned from its investments.

Management Comments

• The Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy.
• The Adviser will compensate all Adviser and Skyview personnel who provide services to the Company.
• Management believes that the final dispositions of any litigation should not have a material adverse effect on the financial position of the Company.

Industry Context

StockSavvy.ai notes that the company operates as a Business Development Company (BDC) and a Regulated Investment Company (RIC), focusing on debt and equity investments in middle-market companies, particularly in the healthcare sector. This aligns with broader trends of BDCs seeking yield in private credit markets.

Comparison to Industry Standards

• The company's expense ratio (net operating expenses as a percentage of average net assets) of 3.41% for the six months ended June 30, 2026, is within the typical range for BDCs, though specific industry benchmarks vary.
• The company's focus on healthcare investments is a common strategy among BDCs seeking specialized sector exposure.
• The weighted average cost price of debt investments at 99.6% of par is a key metric for assessing the valuation of its loan portfolio, though direct comparison to industry peers requires more granular data on loan quality and terms.

Legal Proceedings

• The company is not currently a party to any pending material legal proceedings.

Related Party Transactions

• Investment advisory and administration fees are paid to the Adviser.
• The Adviser has agreed to waive fees or reimburse certain expenses under an expense limitation agreement.
• The Adviser provides office facilities and administrative services.
• The Dealer Manager, NexPoint Securities, Inc., is an affiliate of the Adviser.
• The Adviser has committed $2,275,000 to voluntarily reimburse the Company for certain unrealized losses.

Stakeholder Impact

• Shareholders benefit from the increase in net asset value per share.
• Shareholders may be impacted by the decrease in net investment income.
• The company's focus on healthcare and other sectors may affect the overall risk profile for investors.
• The Adviser and its affiliates receive fees for services, impacting the company's expenses.

Next Steps

• Continue to manage the investment portfolio to generate current income and capital appreciation.
• Monitor portfolio companies for performance and potential risks.
• Manage liquidity and capital resources to meet operational needs and potential future investments.
• Continue to comply with BDC and RIC regulatory requirements.

Key Dates

Recommendation

The company shows growth in net assets and NAV per share, driven by investment gains, which is positive. However, the decline in net investment income and the inherent risks associated with its concentrated and illiquid portfolio suggest a cautious approach. A 'hold' recommendation reflects the balance between positive asset growth and the ongoing risks and lower income generation.

Keywords

Business Development Company, BDC, Investment Company, Senior Secured Loans, Healthcare Investments, Middle-Market Companies, Regulated Investment Company, Closed-End Fund